Skip to content
The Policy VaultThe Policy Vault

MycamineCareFirst (Caremark)

Candidemia, acute disseminated candidiasis, Candida peritonitis and abscesses in adults and pediatric patients age ≥ 4 months

Initial criteria

  • Use for labeled indications only
  • Not established for treatment of candidemia with meningoencephalitis and/or ocular dissemination in pediatric patients <4 months of age
  • Has not been adequately studied in endocarditis, osteomyelitis, and meningoencephalitis due to Candida
  • Efficacy against non-Candida fungi not established